Prenatal Alcohol Exposure Clinical Trial
— ALTEMOOfficial title:
Behavioral Exploration of Cognitive and Emotional Alterations in Adult Individuals Exposed to Alcohol During the Prenatal Period
Verified date | September 2022 |
Source | University Hospital, Lille |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Hypothesis: Individuals presenting with prenatal alcohol exposure (PEA) show emotional abilities deficits, and imbalance between the two systems involved in decision-making according to dual-process models, namely an under-activated reflective system (involved in deliberate behaviors) and an over-activated affective-automatic one (involved in impulsive behaviors). Primary objective: To explore performance (as a percentage of correct answers) in an emotional facial expression decoding task in PEA participants compared to controls without alcohol disorder.
Status | Active, not recruiting |
Enrollment | 144 |
Est. completion date | November 11, 2022 |
Est. primary completion date | November 11, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 60 Years |
Eligibility | Inclusion Criteria: - Man or woman aged between 18 and 60 years - Able to understand and to speak French - Able to understand Note of information and to sign consent form - Available health insurance - Normal (or corrected to normal) vision and audition - For women: Negative pregnancy test or menopausal for at least one year - For Group 1 only : PEA criteria and no alcohol consumption within the three days preceding the experiment. - For Group 2 only : PEA criteria, diagnosed with severe alcohol addiction and currently abstinent (for at least 15 days). - For Group 3 only : Non-alcohol-dependent controls. No alcohol consumption within the three days preceding the experiment and father diagnosed with severe alcohol addiction. - For Group 4 only : Non-alcohol-dependent controls. No alcohol consumption within the three days preceding the experiment. Exclusion Criteria: - Refusal of participation after clear and fair information on the study. - Visual or auditory sensory disability to participate in the study. - Benzodiazepines and / or Antipsychotic concomitant treatment. - History of (or current) neurologic disease - History of (or current) psychiatric disorder (apart alcohol-dependence for the PEA-alcohol-dependent group) - Psychoactive Substance Use or Abuse other than tobacco and alcohol. - Pregnant or breast-feeding women. - Underage (<18 yo) or adults under guardianship, judicial protection, or deprived of liberty. |
Country | Name | City | State |
---|---|---|---|
France | CHRU Lille, Fontan2 | Lille | |
France | CSAPA | Lille |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Lille |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Percentage of correct answers of an emotional facial expression (EFE) | Performance of an emotional facial expression (EFE) decoding task in EPA subjects and compare it to non-alcohol dependent controls | one day | |
Secondary | Psychopathological assessment by Mini International Neuropsychiatric Interview MINI | Presence of psychiatric disorders by a standardized psychiatric interview | one day | |
Secondary | Percentage of correct answers ant latency of behavioral answers | Performance of behavioral tasks | one day | |
Secondary | State-Trait-Anxiety Inventory (STAI) score | Score at STAI STAI is a psychological inventory based on a 4-point Likert scale and consists of 40 questions on a self-report basis | one day | |
Secondary | Beck Depression Inventory score | Score at Beck Depression Inventory The BDI consisted of twenty-one questions about how the subject has been feeling in the last week. Each question had a set of at least four possible responses, ranging in intensity. (0) I do not feel sad/ (1) I feel sad./ (2) I am sad all the time and I can't snap out of it/ (3) I am so sad or unhappy that I can't stand it.
When the test is scored, a value of 0 to 3 is assigned for each answer and then the total score is compared to a key to determine the depression's severity. The standard cut-off scores were as follows:0-9: indicates minimal depression/ 10-18: indicates mild depression/ 19-29: indicates moderate depression/ 30-63: indicates severe depression. |
one day | |
Secondary | Toronto Alexithymia Scale TAS-20 score | Score at TAS-20 The Toronto Alexithymia Scale is a measure of deficiency in understanding, processing, or describing emotions. The current version has twenty statements rated on a five-point Likert scale. ( range : Strongly disagree/Disagree/ Neither agree nor disagree/ Agree/ Strongly agree) | one day |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01911299 -
Choline Supplementation in Children With Fetal Alcohol Spectrum Disorders
|
Phase 2 | |
Completed |
NCT03633149 -
Choices4Health: Intervention to Prevent Substance-exposed Pregnancy
|
N/A | |
Completed |
NCT01149538 -
Postnatal Choline Supplementation in Children With Prenatal Alcohol Exposure
|
Phase 1/Phase 2 |